European XFEL: New Chairman of the Management Board

Physicist Prof Thomas Feurer has taken office as Chairman on 1 January

Physicist Prof Thomas Feurer has assumed the role of the new Chairman of the European XFEL Management Board on 1 January. Hailing from the University of Bern, Feurer was nominated in June 2023 by the European XFEL Council, the supervisory body of the international research organisation, as the successor to Prof. Robert Feidenhans'l.

Prof. Thomas Feurer, Copyright: private
Prof. Thomas Feurer, Copyright: private

The Danish physicist Feidenhans'l had held the position since January 2017 and will continue as an advisor until his retirement in July 2024. 

Feurer's research areas in Bern included laser physics, ultrafast spectroscopy and the development of instruments for research on X-ray lasers such as the European XFEL. He previously worked as a researcher at the Massachusetts Institute of Technology (MIT) for several years and studied physics at the Universities of Würzburg and Jena.

European XFEL Council Chairman Prof Federico Boscherini said: “During the past six months Thomas has already been involved in the development of the 2030 Strategy process and has contributed with important insights. I am sure that his commitment and strategic decisions will further strengthen the leading role of European XFEL in X-ray research, and I look forward to working with him in the coming years.”

On behalf of the European XFEL Council, Boscherini warmly thanked Robert Feidenhans'l for his extraordinary contribution to European XFEL. "As one of my predecessors as Chairman of the Council, Robert was a key figure in the planning and construction of the facility. Later, as Chairman of the Management Board, he successfully guided the facility through the first years of user operation and set the course for the future with the development of the Strategy 2030. We wish him all the best for this new chapter in his life," said Boscherini. 

 The European XFEL Management Board consists of two Managing Directors, Prof Thomas Feurer and Dr Nicole Elleuche, as well as the Scientific Directors Prof Serguei Molodtsov, Dr Sakura Pascarelli and Dr Thomas Tschentscher.

More News

The meetings brought together senior representatives from the European Commission and multiple Member States. (Picture: HALRIC)
The meetings brought together senior representatives from the European Commission and multiple Member States. (Picture: HALRIC)

HALRIC in Brussels

Through direct dialogue with the European Commission and Member States, HALRIC’s Brussels discussions showed how cross-border life science collaboration can unlock efficiency, strengthen European competitiveness, ...

Read more …
Biotech and pharmaceutical companies will now have exclusive access to NexMR’s photo-induced NMR through CrystalsFirst, benefiting from the synergy of two advanced platforms working in tandem.v
Biotech and pharmaceutical companies will now have exclusive access to NexMR’s photo-induced NMR through CrystalsFirst, benefiting from the synergy of two advanced platforms working in tandem. (Image: unsplash/D koi)

NexMR joins forces with CrystalsFirst

CrystalsFirst GmbH, a leader in high-performance structural biology services, and NexMR AG, a pioneer in ultrafast NMR screening, today announced an exclusive partnership to accelerate ...

Read more …
Indivumed and Aptila join forces in a new proteomics collaboration. (Photo: Indivumed)
Indivumed and Aptila join forces in a new proteomics collaboration. (Photo: Indivumed)

Indivumed announces collaboration utilizing Aptila’s proteomics expertise

Indivumed is pleased to announce a close working relationship with Aptila as of August 2025. Aptila’s software suite, DIA-NN, is a leading solution for data-independent ...

Read more …